News | April 07, 2025
Sumitomo Chemical establishes a CRO for Oligonucleotide CDMO business in US
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle AD study
Bloom has pioneered a technology to transform plant waste into valuable chemical products
PRX-PLUS has a unique product feature with its deep-impacting formula
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Positions Curium as leading manufacturer of Lu-177 isotope
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Subscribe To Our Newsletter & Stay Updated
